按组织学亚型预测食管癌未来负担:至2030年发病率的国际趋势
该研究基于12个国家42个登记处至少15年的连续发病数据,用年龄-时期-队列模型预测至2030年食管癌新发病例数和发病率。结果显示所有研究国家食管腺癌新发病例数在2005至2030年间预计快速增加,而食管鳞状细胞癌发病率在多数国家预计继续下降;到2030年荷兰和英国每100名男性中预计有1人在一生中被诊断为食管腺癌。
要点
- 所有研究国家食管腺癌新发病例数2005至2030年预计快速增加,为风险上升与人口结构变化的共同结果。
- 多数国家食管鳞状细胞癌发病率预计继续下降。
- 到2030年荷兰和英国每100名男性中预计有1人一生中被诊断为食管腺癌。
核心结论
- 高收入国家食管腺癌负担预计急剧上升,并已或将超过食管鳞状细胞癌发病率,尤其在男性中。
- 尽管趋势预测存在固有不确定性且存在亚型错分,这些发现凸显食管癌流行病学正在转变,与未来癌症控制规划和临床实践高度相关。
研究设计与样本
- 从国际癌症发病率数据库第五卷至第十卷(VIII-X)中12个国家42个登记处提取按诊断年份、性别、组织学和年龄组的食管癌发病数据,各登记处至少贡献15年连续数据。
- 通过拟合和外推年龄-时期-队列模型预测至2030年的新发病例数和发病率,并分析人口结构变化与风险变化对未来病例数的不同影响。
主要发现
- 所有研究国家食管腺癌新发病例数在2005至2030年间预计快速增加,为风险上升与人口结构变化的共同结果。
- 多数国家食管鳞状细胞癌发病率预计继续下降。
- 到2030年,荷兰和英国每100名男性中预计有1人在一生中被诊断为食管腺癌。
局限性
- 基于趋势的预测存在固有不确定性。
- 存在亚型错分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Rapid increases in the incidence of esophageal adenocarcinoma (EAC) in high-income countries in the past decades have raised public health concerns. This study is the first to predict the future burden of esophageal cancer by histological subtype using international incidence data. METHODS: Data on esophageal cancer incidence by year of diagnosis, sex, histology, and age group were extracted from 42 registries in 12 countries included in the last three volumes (VIII-X) of Cancer Incidence in Five Continents, contributing at least 15 years of consecutive data. Numbers of new cases and incidence rates were predicted up to 2030 by fitting and extrapolating age-period-cohort models; the differential impact of demographic vs. risk changes on future cases were examined. RESULTS: The number of new AC cases is expected to increase rapidly 2005-2030 in all studied countries as a combined result of increasing risk and changing demographics. In contrast, the incidence of esophageal squamous cell carcinoma (ESCC) is predicted to continue decreasing in most countries. By 2030, 1 in 100 men in the Netherlands and the United Kingdom are predicted to be diagnosed with EAC during their lifetime. CONCLUSIONS: The burden from EAC is expected to rise dramatically across high-income countries and has already or will surpass ESCC incidence in the coming years, especially among men. Notwithstanding the inherent uncertainties in trend-based predictions and in subtype misclassification, these findings highlight an ongoing transition in the epidemiology of esophageal cancer that is highly relevant to future cancer control planning and clinical practice.
引用
- Arnold M, Laversanne M, Brown LM, et al. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030. Am J Gastroenterol. 2017. PMID: 28585555. doi:10.1038/ajg.2017.155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。